Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 microRNA and cancer.

Literature DB >> 20422339

microRNA and cancer.

Mengfeng Li¹, Jun Li, Xiaofan Ding, Mian He, Shi-Yuan Cheng.

Abstract

MicroRNAs (miRNAs), a class of small, regulatory, non-coding RNA molecules, display aberrant expression patterns and functional abnormalities in human diseases including cancers. This review summarizes the abnormally expressed miRNAs in various types of human cancers, possible mechanisms underlying such abnormalities, and miRNA-modulated molecular pathways critical for cancer development. Practical implications of miRNAs as biomarkers, novel drug targets and therapeutic tools for diagnosis, prognosis, and treatments of human cancers are also discussed.

Entities: Disease Species

Mesh：

Substances：

Year: 2010 PMID： 20422339 PMCID： PMC2895440 DOI： 10.1208/s12248-010-9194-0

Source DB: PubMed Journal: AAPS J ISSN： 1550-7416 Impact factor: 4.009

112 in total

1. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.

Authors: Takatsugu Kan; Fumiaki Sato; Tetsuo Ito; Nobutoshi Matsumura; Stefan David; Yulan Cheng; Rachana Agarwal; Bogdan C Paun; Zhe Jin; Alexandru V Olaru; Florin M Selaru; James P Hamilton; Jian Yang; John M Abraham; Yuriko Mori; Stephen J Meltzer
Journal: Gastroenterology Date: 2009-05 Impact factor: 22.682

2. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification.

Authors: Basile Stamatopoulos; Nathalie Meuleman; Benjamin Haibe-Kains; Pascale Saussoy; Eric Van Den Neste; Lucienne Michaux; Pierre Heimann; Philippe Martiat; Dominique Bron; Laurence Lagneaux
Journal: Blood Date: 2009-01-14 Impact factor: 22.113

3. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

Authors: Danit Lebanony; Hila Benjamin; Shlomit Gilad; Meital Ezagouri; Avital Dov; Karin Ashkenazi; Nir Gefen; Shai Izraeli; Gideon Rechavi; Harvey Pass; Daisuke Nonaka; Junjie Li; Yael Spector; Nitzan Rosenfeld; Ayelet Chajut; Dalia Cohen; Ranit Aharonov; Mahesh Mansukhani
Journal: J Clin Oncol Date: 2009-03-09 Impact factor: 44.544

Review 4. MicroRNAs in Cancer.

Authors: Ramiro Garzon; George A Calin; Carlo M Croce
Journal: Annu Rev Med Date: 2009 Impact factor: 13.739

5. Decreased expression of microRNA-143 and -145 in human gastric cancers.

Authors: Takeshi Takagi; Akio Iio; Yoshihito Nakagawa; Tomoki Naoe; Nobuhiko Tanigawa; Yukihiro Akao
Journal: Oncology Date: 2009-05-12 Impact factor: 2.935

6. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.

Authors: Xiaoxia Hu; Dusten M Macdonald; Phyllis C Huettner; Zhihui Feng; Issam M El Naqa; Julie K Schwarz; David G Mutch; Perry W Grigsby; Simon N Powell; Xiaowei Wang
Journal: Gynecol Oncol Date: 2009-06-05 Impact factor: 5.482

7. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.

Authors: Nora Bandi; Samuel Zbinden; Mathias Gugger; Marlene Arnold; Verena Kocher; Lara Hasan; Andreas Kappeler; Thomas Brunner; Erik Vassella
Journal: Cancer Res Date: 2009-06-23 Impact factor: 12.701

8. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA.

Authors: Deo Prakash Pandey; Didier Picard
Journal: Mol Cell Biol Date: 2009-05-04 Impact factor: 4.272

9. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.

Authors: E J Noonan; R F Place; D Pookot; S Basak; J M Whitson; H Hirata; C Giardina; R Dahiya
Journal: Oncogene Date: 2009-03-02 Impact factor: 9.867

10. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.

Authors: Scott Valastyan; Ferenc Reinhardt; Nathan Benaich; Diana Calogrias; Attila M Szász; Zhigang C Wang; Jane E Brock; Andrea L Richardson; Robert A Weinberg
Journal: Cell Date: 2009-06-12 Impact factor: 41.582

58 in total

1. Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.

Authors: Guan Sun; Shushan Yan; Lei Shi; Zhengqiang Wan; Nan Jiang; Min Li; Jun Guo
Journal: Cancer Biother Radiopharm Date: 2015-03-26 Impact factor: 3.099

Review 2. Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases.

Authors: Xue-Feng Jin; Ning Wu; Lv Wang; Jin Li
Journal: Cell Mol Neurobiol Date: 2013-04-30 Impact factor: 5.046

3. Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes.

Authors: Hyang Sook Seol; Yoshimitsu Akiyama; Shu Shimada; Hee Jin Lee; Tae Im Kim; Sung Min Chun; Shree Ram Singh; Se Jin Jang
Journal: Cancer Lett Date: 2014-07-22 Impact factor: 8.679

4. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.

Authors: Xiaowei Peng; Peiguo Cao; Jingjing Li; Dong He; Shuang Han; Jianda Zhou; Guolin Tan; Wei Li; Fenghui Yu; Jianjun Yu; Zan Li; Ke Cao
Journal: Cancer Biol Ther Date: 2015 Impact factor: 4.742

5. MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells.

Authors: Cheng-Der Wu; Yuan-Sung Kuo; Han-Chung Wu; Chin-Tarng Lin
Journal: J Biomed Sci Date: 2011-11-07 Impact factor: 8.410

6. Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network.

Authors: Jieqing Zhu; Gaofeng Xiong; Hanjiang Fu; B Mark Evers; Binhua P Zhou; Ren Xu
Journal: Cancer Res Date: 2015-03-05 Impact factor: 12.701

Review 7. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.

Authors: Rajendra Awasthi; Michael John Rathbone; Philip Michael Hansbro; Mary Bebawy; Kamal Dua
Journal: Drug Deliv Transl Res Date: 2018-02 Impact factor: 4.617

8. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.

Authors: Zhenze Zhao; Xiuye Ma; Derek Sung; Monica Li; Adam Kosti; Gregory Lin; Yidong Chen; Alexander Pertsemlidis; Tzu-Hung Hsiao; Liqin Du
Journal: RNA Biol Date: 2015 Impact factor: 4.652

9. Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

Authors: Haiyan Zhao; Hao Xu; Luchen Xue
Journal: Oncol Lett Date: 2017-09-14 Impact factor: 2.967

10. microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.

Authors: Yeunpo Chiang; Yongxi Song; Zhenning Wang; Zhuangkai Liu; Peng Gao; Jiwang Liang; Jinliang Zhu; Chengzhong Xing; Huimian Xu
Journal: Exp Ther Med Date: 2011-12-28 Impact factor: 2.447